AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

Author(s): Tristan Reuillon, Simon E. Ward, Paul Beswick

Journal Name: Current Topics in Medicinal Chemistry

Volume 16 , Issue 29 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The neurotransmitter glutamate and its receptors have long been of interest to scientists involved in pharmaceutical research since dysfunction of the glutamatergic signalling pathway has been associated with the pathophysiology of several psychiatric and neurological disorders. The research on AMPAR positive allosteric modulators offers opportunities to modulate fast excitatory synaptic transmission and identify new potential therapeutic agents for a range of neurodiseases. The field of AMPAR modulators continues to be a dynamic area of drug discovery with a pronounced diversification of the chemotypes explored in recent years. This article reviews literature published in this area in the last 6 years, focusing on the new core templates, some derived from high-throughput screens, with an emphasis on structure-activity relationships, drug metabolism and pharmacokinetics properties, and pharmacological profiles of these series.

Keywords: AMPA receptor, AMPAR positive modulators, Cognition deficit, DMPK properties, Glutamate, Ion channel, X-ray crystallography.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 19 October, 2016
Page: [3536 - 3565]
Pages: 30
DOI: 10.2174/1568026616666160627114507
Price: $65

Article Metrics

PDF: 57
PRC: 1